Chandra Bhagat Pharma (BOM:542934) Debt-to-Asset : 0.29 (As of Sep. 2023)

View and export this data going back to 2020. Start your Free Trial

What is Chandra Bhagat Pharma Debt-to-Asset?

Chandra Bhagat Pharma's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Sep. 2023 was ₹132 Mil. Chandra Bhagat Pharma's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Sep. 2023 was ₹44 Mil. Chandra Bhagat Pharma's Long-Term Debt & Capital Lease ObligationTotal Assets for the quarter that ended in Sep. 2023 was ₹597 Mil. Chandra Bhagat Pharma's debt to asset for the quarter that ended in Sep. 2023 was 0.29.

Chandra Bhagat Pharma Debt-to-Asset Historical Data

The historical data trend for Chandra Bhagat Pharma's Debt-to-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Chandra Bhagat Pharma Debt-to-Asset Chart

Chandra Bhagat Pharma Annual Data

Trend

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

Debt-to-Asset

Get a 7-Day Free Trial

0.38

0.40

0.38

0.29

0.31

Chandra Bhagat Pharma Semi-Annual Data
	Mar17	Mar18	Mar19	Mar20	Sep20	Mar21	Sep21	Mar22	Sep22	Mar23	Sep23
Debt-to-Asset	Get a 7-Day Free Trial						0.35	0.29	0.29	0.31	0.29

Competitive Comparison of Chandra Bhagat Pharma's Debt-to-Asset

For the Drug Manufacturers - Specialty & Generic subindustry, Chandra Bhagat Pharma's Debt-to-Asset, along with its competitors' market caps and Debt-to-Asset data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Chandra Bhagat Pharma's Debt-to-Asset Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Chandra Bhagat Pharma's Debt-to-Asset distribution charts can be found below:

* The bar in red indicates where Chandra Bhagat Pharma's Debt-to-Asset falls into.

Chandra Bhagat Pharma Debt-to-Asset Calculation

Debt to Asset measures the financial leverage a company has.

Chandra Bhagat Pharma's Debt-to-Asset for the fiscal year that ended in Mar. 2023 is calculated as

Debt-to-Asset	=	Total Debt			/	Total Assets
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Assets
	=	(150.171	+	39.276)	/	605.834
	=	0.31

Chandra Bhagat Pharma's Debt-to-Asset for the quarter that ended in Sep. 2023 is calculated as

Debt-to-Asset	=	Total Debt			/	Total Assets
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Assets
	=	(131.832	+	43.621)	/	596.547
	=	0.29

Chandra Bhagat Pharma (BOM:542934) Debt-to-Asset Explanation

In the calculation of Debt-to-Asset, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by Total Assets.

Chandra Bhagat Pharma Debt-to-Asset Related Terms

Thank you for viewing the detailed overview of Chandra Bhagat Pharma's Debt-to-Asset provided by GuruFocus.com. Please click on the following links to see related term pages.

Chandra Bhagat Pharma (BOM:542934) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Chandra Bhagat Pharma Ltd (BOM:542934) » Definitions » Debt-to-Asset

Traded in Other Exchanges

N/A

Address

Doctor Ambedkar Road, 323-F Bhagat Bhuvan, Matunga (East), Mumbai, MH, IND, 400019

Website

https://www.cbcpharma.com

Chandra Bhagat Pharma Ltd is engaged in the business of marketing pharmaceutical critical care and health care products. The company provides a pharmaceutical formulation in therapeutic categories for formulations such as Anti-cancer (Oncology), Antibiotics, Anesthesia, Hormones, Orthopedic, Cardiac, Cardiovascular, Anti-fungal, Antiviral, Pediatrics, Cardiology, Nephrology, Neurology, and others. It is also engaged in promoting and marketing Active Pharmaceuticals Ingredients (APIs) in India.

Chandra Bhagat Pharma (BOM:542934) Headlines

No Headlines